Home > Financial Ratios > VALIANT LABORATORIES

VALIANT LABORATORIES
Core EBITDA Margin

    Back to All Ratios
VALIANT LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Margin(%) -4.6210.50

What is the latest Core EBITDA Margin ratio of VALIANT LABORATORIES ?

The latest Core EBITDA Margin ratio of VALIANT LABORATORIES is -4.62 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar2024-4.62
Mar202310.50

How is Core EBITDA Margin of VALIANT LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2024 -4.62
Negative
Mar2023 10.5 -

Other Financial Ratios of VALIANT LABORATORIES


Compare Core EBITDA Margin ratio of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹470.2 Cr -2.6% -11.6% -15.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,498.0 Cr 1.9% -2.1% -6.2% Stock Analytics
DIVIS LABORATORIES ₹165,838.0 Cr 2.7% -5.6% 25.2% Stock Analytics
CIPLA ₹129,330.0 Cr 3.4% 7.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,235.0 Cr 0.6% 4.4% 9.6% Stock Analytics
DR REDDYS LABORATORIES ₹107,211.0 Cr 3.2% 1.6% -8.4% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-2.6%

-11.6%

-15.5%

SENSEX

0.5%

-1.3%

0.9%


You may also like the below Video Courses